| H |
|
Haemoperitoneum Associated with Ovulation in Women with Autosomal Recessive Bleeding Disorders
|
| Payne JH, Maclean RM, Hampton KK, Makris M |
| |
|
Haemophilia A in a Women Caused By Swyer-Syndrom and a Missense Mutation in Factor VIII Gene
|
| RM Loreth, J Oldenburg, U Budde, FH Herrmann |
| |
|
Haemophilia B in Female
|
| Badereddine L, Baghli L, Benhadda B, Costa C |
| |
|
Haemophilic Arthropathy: Contribution of Clinical, X-Ray and MRI Scores in its Diagnosis and Modification of Treatment
|
| Pergantou H, Matsinos G, Papadopoulos A, Platokouki H, Aronis S |
| |
|
Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases
|
| Tanashian M, Suslina Z, Ionova V, Maximova M, Karabasova M, Lyutova L |
| |
|
Haemostasis Is Regulated through Nicotinic Acetylcholine Receptors
|
| Skok M, Zverkova A, Grailhe R, Changeux JP |
| |
|
Haemostasis System State, Cytokines, Soluble Cell Adhesion Molecules in Atherosclerosis due to Low-Level Ecological and Professional Irradiation
|
| Kruchinsky N, Teplyakov A |
| |
|
Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT)
|
| Ralis H, Jennings GM, Davies DA, Morris RJ, Woodcock JP, Giddings JC |
| |
|
Haemostatic and Inflammatory Markers in Coronary Heart Disease
|
|
| |
|
Haemostatic Characters during Liver Transplantation with Preoperative DIC
|
| Peng L, Xiao P, Mu Y, Cao JY, Zhuang YP |
| |
|
Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study
|
| Morange PE, Bickel C, Nicaud V, Rupprecht HJ, Peetz D, Lackner KJ, Blankenberg S, Tiret L |
| |
|
Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A
|
| Sørensen B, Persson E, Norengaard L, Christiansen K, Ingerslev J |
| |
|
Haplotypes of the Fibrinogen Genes, Plasma Fibrinogen Levels and the Risk of Deep Venous Thrombosis
|
| Uitte de Willige S, De Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM |
| |
|
Health-related Quality of Life in Adult Patients with Haemophilia – Assessment with a New Disease-specific Questionnaire (Haem-A-QoL)
|
| v. Mackensen S, Gringeri A |
| |
|
Hematopoeitic Lineage Cell-Specific Protein-1 (HS1) Is a Functionally Important Signaling Molecule Downstream of GPVI Stimulation in Platelets
|
| Kahner BN, Dorsam RT, Kunapuli SP |
| |
|
Hematopoietic Stem Cells and Their Niche
|
| Arai F, Ito K, Suda T |
| |
|
Hemizygous Antithrombin-Deficiency Presenting with a Thrombosis at Birth
|
| Kristensen SR, Käehne M, Petersen NE |
| |
|
Hemophilia B Mice Have Delayed Wound Healing
|
| Meng ZH, Lenkowski A, Hoffman M, Hedner U, Roberts HR, Monroe DM |
| |
|
Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts
|
| Suslina Z, Ionova V, Maximova M, Tanashian M, Karabasova M, Lyutova L |
| |
|
Hemorheology, Hemostasis in Patients with Arterial Hypertension
|
| Suslina Z, Ionova V, Maximova M, Tanashian M, Karabasova M, Lyutova L |
| |
|
Hemorrhagic risk in Female Carriers of Hemophilia
|
| Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AHJT, Ploos van Amstel JK, van der Bom JG, van Diemen-Homan JEM, Rosendaal FR |
| |
|
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway
|
| Safa O, Smirnov M, Diaz D, Triscott M, Toulon P, Tripodi A |
| |
|
Hemostatic Abnormalities in Oncolgic Patients
|
| Pérez-Montes R, Colorado M, Yañez L, Nieto MA, Sedano C, Iriondo A |
| |
|
Hemostatic Alterations in Pediatric Leukemias
|
| Giordano P, Del Vecchio GC, Saracco P, Molinari AC, Altomare M, Piacente L, Perutelli P, Crescenzio N, Russo G, Santoro N, De Mattia D |
| |
|
Hemostatic and Inflammatory Disturbances are Present in Ischemic Stroke
|
| Rooth E, Antovic JP, Kaponides G, von Arbin M, Wahlgren NG, Antovic A, Blombäck M, 1 , Wallen NH |
| |
|
Hemostatic Changes in Patients with Malaria
|
| Marques HO, Alexandre MA, Oliveira VM, Marreira L, Lacerda MVG, Alecrim MCG, Morelli VM, Lourenço DM |
| |
|
Hemostatic Effects of Long-Term Expression of Activated Murine FVII in Normal and Hemophilic Mice
|
| Aljamali MN, Margaritis P, Camire RM, High KA |
| |
|
Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo
|
| Okamura Y, Takeoka S, Suzuki H, Murata M, Handa M, Ikeda Y |
| |
|
Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo
|
| Takeoka S, Okamura Y, Suzuki H, Murata M, Handa M, Ikeda Y |
| |
|
Hemostatic Factors and Serum Lipids in Patients with Angina Pectoris Who Underwent Coronary Angiography
|
| Ihara A, Kawamoto T, Matsumoto K |
| |
|
Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study)
|
| Hoffmann JN, Wiedermann C, Jürs M, Kienast J, Briegel J, Strauss R, Warren B, Opal O |
| |
|
Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study)
|
| Levine RL, Hergenroeder GW, Miller III, CC1 , Francis JL |
| |
|
Heparin Has Variable Effects on the Release of Glycosylphosphatidylinositol-Lipid Anchored TFPI from Human Umbilical Vein Endothelial Cells
|
| Ellery P, Hardy K, Oostryck R, Adams M |
| |
|
Heparin Induced Thrombocytopenia (HIT) in Recurrent Acute Thrombophlebitis in Cancer Patients: Killer Clot, or Killer Drugs
|
| Corinaldesi G, Corinaldesi C |
| |
|
Heparin Induced Thrombocytopenia (HIT) with Thrombosis – Case Report
|
| Lokar L, Urlep-[Scaron]alinovi[cacute] V, Majcen-Vivod B, Mara[ccaron]i[ccaron] I |
| |
|
Heparin Induced Thrombocytopenia Type II In Cardiac Hemodialysis Brazilian Patients
|
| Oliveira SC, Cavalheiro-Filho C, Rached RA, Costa MC, Bydlowski SP, Chamone DAF |
| |
|
Heparin Induces Release of Osteoprotegerin (OPG)
|
| Vik A, Brodin E, Sveinbjørnsson B, Hansen JB |
| |
|
Heparin Is a Multifaceted Anti-Adhesive Agent: Inhibition of Phosphatidylserine (PS)-Positive Erythrocyte Binding to Matrix Thrombospondin (TSP)
|
| Setty BNY, Gayen-Betal S, Stuart MJ |
| |
|
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
|
| Julian J, Kearon C, Solymoss S, Douketis J, Ockelford P, Jackson S, Turpie AGG, McCarty D, MacKinnon B, Hirsh J, Gent M, Ginsberg JS |
| |
|
Heparin Monitoring During Haemodialysis in Children
|
| Ignjatovic V, Monagle P, Newall F, Furmedge J, Summerhayes R, Gan A, Jones C, Ross-Smith M, Ellis A, Chan A |
| |
|
Heparin Platelet Factor 4 Antibody Formation in Patients Receiving Bivalirudin or Heparin for Off-Pump Coronary Artery Bypass Surgery
|
| Francis JL, Drexler A, Walker J, Rathmann K |
| |
|
Heparin Selectively Inhibits CD11b High Affinity Neo-epitope Expression in vivo During Coronary Artery Bypass Surgery
|
| Orr Y, Taylor JM, Bannon PG, Geczy C, Kritharides XX |
| |
|
Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation
|
| Renné T, Flodgaard H, Burfeind P, Schuh K, Walter U, Müller-Esterl W |
| |
|
Heparin-Induced Thrombocytopenia (HIT) and Danaparoid (Orgaran®): Review of 1479 Reported Clinical Outcomes of Patients Treated Between 1981 and 2004
|
| Magnani H, Gallus A |
| |
|
Heparin-induced Thrombocytopenia in Patients after Extracorporeal Circulation Surgery
|
| Roitman E, Schegolkova T, Dementieva I, Dashkova N, Morosov Yu, Ragimov A |
| |
|
Heparinization of the Pancreatic Islet Surface as a Mean to Reduce Harmful Blood Clotting after Intraportal Islet Transplantation
|
| Cabric S, Sanchez J, Larsson R, Nilsson B, Korsgren O |
| |
|
Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis
|
| Borg JY, Chopard C, Le Cam-Duchez V, Dureuil B, Veber B |
| |
|
Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department
|
| Francis JL, Drexler A, Walker J, Duncan MK, Ahmad S |
| |
|
Heparins Are Transported Across Rat Gastric Mucosa. Studies in a Verticle Diffusion Chamber
|
| Moazed B, Hiebert L |
| |
|
Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
|
| Rega G, Kaun C, Weiss TW, Demyanets S, Frey M, Maurer G, Huber K, Wojta J |
| |
|
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver
|
| Suzuki M, Murata M, Matsubara Y, Shiomi T, Yokoyama K, Ambo H, Uchida T, Ishihara H, Shibano T, Okada Y, Ikeda Y |
| |
|
Hepcidin: A Link between Anemia, Inflammation and Liver Function in HD Patients?
|
| Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M |
| |
|
Heptest®-POC-Hi, a New Simple One-Step Point of Care (POC) Anti-Xa Clotting Assay for Monitoring Heparin Activity During Cardiac Surgery
|
| Yin ET, Rozin T |
| |
|
Hereditary Angioedema with Normal C1 Esterase Inhibitor: Studies on Two Families with Affected Women and Men
|
| Dewald G, Bork K |
| |
|
Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES)
|
| Brouwer JLP, Veeger NJGM, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, Van der Meer J |
| |
|
Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES)
|
| Brouwer JLP, Ten Kate MK, Veeger NJGM, Van der Schaaf W, Kluin-Nelemans HC, Van der Meer J |
| |
|
Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide
|
| Wang Z, Zhang Z, Dong N, Bai X, Zhang W, Ruan C |
| |
|
Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study
|
| Tosetto A, Castaman G, Simioni M, Giacomelli S, Madeo D, Rodeghiero F |
| |
|
Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis
|
| Middeldorp S, Goglidze I, Meijers JCM, Büller HR, Smet de MD |
| |
|
Heritability of Quantitative Phenotypes: Lipids, Coagulation, Pro-Inflammatory, Cell Adhesion and Anthropometric Markers in the Presence or Absence of Coronary Artery Disease (CAD) in Parents
|
| Rao VS, Mukherjee M, Kanjilal S, Natesha B, Kumar R, Iyengar SS, Kakkar VV |
| |
|
Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD)
|
| Mukherjee M, Shankar J, Rao VS, Ganapathy P, Natesha B, Kanjilal S, Iyengar SS, Kakkar VV |
| |
|
Heterogeneity of Integrin Expression on Platelet Microparticles. Use of A Snake Venom Disintegrin as a Functional Probe
|
| Dotsenko O, Clutterbuck R, Lu X, Kakkar VV, Scully MF |
| |
|
Heterogeneous Expression of Components of Protein C (PC) System in Human Colon Cancer Tissue
|
| Wojtukiewicz MZ, Sierko E, Zimnoch L, Kisiel W |
| |
|
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function
|
| Bennett JS, Li W, Metcalf DG, Gorelik R, Li R, Mitra N, Nanda V, Law PB, Lear JD, DeGrado WF |
| |
|
Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion
|
| Vu D, de Moerloose P, Batorova A, Horvathova D, Palumbo L, Neerman-Arbez M |
| |
|
HGF Activates Its Met Receptor on Human Platelets and Inhibits Platelets Aggregation
|
| Sinigaglia F, Pietrapiana D, Sala M, Prat M |
| |
|
Hic-5 Promotes Endothelial Cell Migration
|
| Avraamides C, Bromberg ME, Panetti TS |
| |
|
High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
|
| Van Dreden P, Exner T, Fontaine S, Rousseau A, Edouard A, Bonnet M, Woodhams B |
| |
|
High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study
|
| Gurbel PA, Bliden KP, Fissha M, Yoho J, Kreutz R, Zaman K, Tantry U |
| |
|
High Incidence and Transitory Nature of Acquired Resistance to Activated Protein C (aAPCR) in Patients with Multiple Myeloma
|
| Elice F, Zangari M, Fink L, Tricot G |
| |
|
High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients
|
| Taliani MR, Vedovati MC, Caponi C, Felici A, Becattini C, Agnelli G |
| |
|
High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma
|
| Simanek R, Vormittag R, Hassler M, Schwarz M, Zielinski C, Marosi C, Pabinger I |
| |
|
High Inter-Device Variation of the PFA-100™ Platelet Function Analyzer
|
| Loreth RM, Blauth G, Schreyer B, Albert FW |
| |
|
High Levels of Anti-protein Z Immunoglobulin G and M Antibodies, Persistent Lupus Anticoagulant and Thrombosis
|
| Vormittag R, Zoghlami C, Pabinger I |
| |
|
High Levels of Lp(a) in Complicated Pregnancies and Women with Recurrent Fetal Loss and Successful Treatment with Dalteparin
|
| Rott H, Halimeh S, Kappert G, Trobisch H, Nowak-Goettl U |
| |
|
High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC
|
| Hideo W, Yamada S, Kobayashi T, Hiroshi Shiku, Abe Y, Nishioka J, Nobori N, Maruyama I |
| |
|
High Molecular Weight Fibrin Degradation Products Prevail over D-Dimer in Normal and Pathological Plasmas
|
| Filatov V, Kogan A, Kara A |
| |
|
High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells
|
| Khan MM, Bradford HN, Isordia-Salas I, Espinola R, Liu B, Sartor RB, Colman RW |
| |
|
High Platelet Reactivity is a Risk Factor for Post-Discharge Ischemic Complications Following Elective Coronary Stenting
|
| Kevin B, Udaya T, Kirk G, Kevin H, Jason Y, Paul AG |
| |
|
High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency
|
| Girolami A, Sartori MT, Zanon E, Lombardi AM, Vettore S |
| |
|
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
|
| Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus A, Planes A, Passera R, Rouillon A |
| |
|
High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
|
| Paniccia R, Costanzo M, Valente S, Lombardi A, Giglioli C, Bernardo F, Lazzeri C, Prisco D, Gensini GF, Abbate R |
| |
|
High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer]
|
| Shenkman B, Matetzky S, Hod H, Lubetsky A, Kotev-Emeth S, Savion N, Varon D |
| |
|
High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
|
| Poli D, Antonucci E, Cecchi E, Marcucci R, Bolli P, Zanazzi M, Salvadori M, Abbate R, Gensini GF, Prisco D |
| |
|
High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES)
|
| Van Vlijmen EFW, Brouwer JLP, Veeger NJGM, De Graeff PA, Van der Meer J |
| |
|
High Sensitivity of Monochloroacetic Acid 1% Clot Lysis Test for Diagnosis of Severe FXIII Deficiency
|
| Eshghi P, Sanei-Moghaddam E, Anwar R, Jazebi H, Ala F |
| |
|
High Shear Platelet Function Is Associated with Major Adverse Events in Patients with Stable Cardiovascular Disease (CVD) Despite Aspirin Therapy
|
| Christie D, Kottke-Marchant K, Gorman R |
| |
|
High Success Rate of Immune Tolerance Induction with Recombinant Factor VIII (rFVIII) in High-responders with Intron 22 Inversions (int22inv) in the F8 Gene
|
| Rocino A, Santagostino E, Mancuso ME, Mannucci PM |
| |
|
High Titre Inhibitor in a Paediatric Haemophilia B Patient
|
| Lischetzki G, Topf HG, Klinge J |
| |
|
High Versus Low Doses of Low-Molecular-Weight Heparin for the Treatment of Superficial Vein Thrombosis of the Legs. A Double-blind, Randomized Trial
|
| Prandoni P |
| |
|
Higher Coagulation Activity and anti-Xa levels During Dalteparin Treatment in Women with Unstable Coronary Artery Disease
|
| Oldgren J, Johnston N, Wallentin L, Siegbahn A |
| |
|
Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR
|
| Ames PRJ, Ciampa A, Brancaccio V, Iannaccone L, Margaglione M |
| |
|
High-Level Expression of Porcine Factor VIII from Genetically-Modified Bone Marrow-Derived Cell Types
|
| Gangadharan B, Ide L, Spencer HT, Doering CB |
| |
|
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity
|
| Bongers TN, Lisman T, Adelmeijer J, Janssen HLA, de Maat MPM, de Groot PG, Leebeek FWG |
| |
|
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization
|
| Matsumoto Y, Takizawa H, Gong X, Le S, Lockyer S, Okuyama K, Yoshitake M, Kambayashi J, Tandon NN |
| |
|
Highly Sensitive and Specific Test Panel Results in an Improved Laboratory Diagnosis of the Lupus Anticoagulant 1998–2004
|
| Rock Jr WA, Moore AS, Moore PJ, Johnson WD |
| |
|
HIT-II: Therapeutical Use of Fondaparinux (Our Experience)
|
| Girtovitis F, Ioannidis G, Makris PE |
| |
|
HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells
|
| Morishita E, Yamazaki K, Sekino T, Yamazaki M, Asakura H, Nakao S, Ohtake S |
| |
|
Home Treatment Diaries: Evaluation of a Handheld Communicator Brand Electronic System for the Documentation of Hemophilia Therapy
|
| Mondorf W, Pollmann H |
| |
|
Home Treatment in Pulmonary Embolism
|
| Olsson C-G, Linné R, Jonson B, Bajc M |
| |
|
Home Treatment of Bleeding Episodes in Haemophiliacs With Inhibitors: Cost-Effectiveness of Three on-Demand Strategies in Germany
|
| Huth-Kühne A, Fischer R, Zimmermann R, Krause M, Scharrer I |
| |
|
Home Treatment of Patients with Hemophilia Using Clotting Factor Concentrates VIII and IX ‘Ahemphil A’ and ‘Ahemphil B’
|
| Lopatina EG, Plyushch OP, Severova TV, Yastrubinetskaya OI |
| |
|
Homocystein and Hemostatic Variables in Young Postinfarction Patients
|
| Dobrovolsky A, Vitsenya M, Titaeva E, Goltsova K, Storozhilova A, Titov V, Suchoverchova A, Kovalenko T, Patruchev L |
| |
|
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants
|
| Carluccio MA, Ancora MA, Massaro M, Carluccio M, Distante A, Storelli C, De Caterina R |
| |
|
Homocysteine and Thrombosis in Thai Children: A Case-Control Study
|
| Nongnuch S, Pornsri T, Anannit V, Kalayanee A, Sukanya C, Ampaiwan C |
| |
|
Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
|
| Antonijevic N, Sango V, Novakovic I, Mirkovic D, Perunicic J, Vukcevic V, Stanojevic M, Matic M, Vasiljevic Z, Ostojic M |
| |
|
Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
|
| den Heijer M, Willems H, Blom H, Gerrits WBJ, Cattaneo M, Eichinger S, Rosendaal FR, Bos G |
| |
|
Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion
|
| Lodigiani C, Quaglia I, Ferrazzi P, Rossi LS, Bellatorre AG, Mari D, Rota LL |
| |
|
Homocysteine, Genetic Venous Thrombosis Risk Factors in Patients on Maintenance Hemodialysis Underwent Vascular Access Thrombosis
|
| Kozlova T, Shilo V |
| |
|
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
|
| Gori AM, Corsi AM, Cellai AP, Alessandrello Liotta A, Falciani M, Lapini I, Fedi S, Ferrucci L, Abbate R, Gensini GF |
| |
|
Homozygous Protein C Deficiency in an Affected Fetus – Is There a Case for Early Elective Delivery?
|
| Minford A, Parapia LA |
| |
|
Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin
|
| Carneiro JDA, Matsumoto LA, Machado R, Diniz EMA, Krebs VLJ, D'Amico EA |
| |
|
Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
|
| Long GL, Brandao LR, Wentworth C, Block K, Gibb CB, Peerschke EIB, Castellone DD, DiMichele DM |
| |
|
Hormonal Regulation of the Anticoagulant Protein S
|
| Hughes Q, Staton J, Watson M, Cole V, Baker R |
| |
|
Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
|
| Scarabin PY, Plu-Bureau G, Oger E, Conard J, Meyer G, EmmerichLévesque JH, Trillot N, Barrellier MT, Wahl D |
| |
|
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
|
| Giuliano V, Iorio A, Castellani D, Gizzi S, Palmerini F, Sabatino G, Morelli O, Clerici C, Filippucci E, Baldoni M, Nenci GG, Morelli A |
| |
|
How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals?
|
| El-Ali M, Theodoridis T, Galea B, Gougopoulou D, Letsas K, Karida A, Kounas S, Kardaras F, Christopoulou–Cokkinou V |
| |
|
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective
|
| Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K |
| |
|
How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
|
| Casonato A, Bertomoro A, Cattini MG, Gallinaro L, Pontara E, Sartorello F, Soldera C, Padrini R, Pagnan A |
| |
|
Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran
|
| Boström SL, Carlsson A, Jansson L, Nelander K, Svensson D |
| |
|
Human Thrombospondin-1 in Twelve Von Willebrand Factor/FVIII Coagulation Factor Concentrates
|
| Suiter TM |
| |
|
Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing
|
| Staelens S, Vanhoorelbeke K, Ngo TH, Vauterin S, Pareyn I, Stassen JM, Deckmyn H |
| |
|
Hydraulic Firmness of Clots and Fibrinogen Concentration
|
| Savushkin AV |
| |
|
Hydraulic Resistance of Fibrin Clot: Influence of Fibrinogen Concentration
|
| Savushkin AV |
| |
|
Hydrogen Peroxide Activation of Platelet-Derived Growth Factor D-chain Transcription Is Mediated by the Winged Helix-Turn-Helix Protein Ets-1 and its Interplay with Sp1
|
| Liu MY, Eyries M, Zhang C, Santiago FS, Khachigian LM |
| |
|
Hydrolysis of Platelet GpV by Alpha-Thrombin: Effects of GpIb and Ligands of Thrombin Exosite I and II
|
| De Candia E, De Filippis V, De Cristofaro R |
| |
|
Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
|
| Batora I, Batorova A, Zimanova J, Ulicna O, Vojtech I, Gavornik P, Gaspar L |
| |
|
Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
|
| Ferroni P, Lisi F, Moricone A, Martini F, Lisi R, Rinaldi L, Fishel S, Davì G, Basili S |
| |
|
Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting
|
| Bliden K, Tantry U, Guyer K, Herzog W, Kreutz R, Gurbel PA |
| |
|
Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
|
| Isermann B, Vinnikov I, Herzog S, Huntscha S, Thati M, Bierhaus A, Nawroth PP |
| |
|
Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
|
| Fareed J, Hoppensteadt D, Iqbal O, Jeske WP, Walenga JM, Dietcher S, Demir |
| |
|
Hyperhomocysteinemia Is a Significant Risk Factor for Recurrent Early Pregnancy Loss in Russia
|
| Shmeleva V, Dmitrieva A, Papayan L |
| |
|
Hyperhomocysteinemia Relapsing after Vitaminous Treatment: Relationship Between C677T Methylenetetrahydrofolatereductase (MTHFR) Genotype and Basal Homocysteine Level
|
| Kozlova T, Taratuta T, Bokarev I |
| |
|
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients
|
| Hendler MF, Alberto MF, Meschengieser SS, Bernasconi A, Heguilen R, Casais P, Sanchez-Luceros A, Aixalá M, Lazzari MA |
| |
|
Hypertonic Stress Alters the Yield and Type of Microparticles Produced by Haemopoietic Cells
|
| Clutterbuck R, Heward J, Dotsenko O, Kakkar VV, Scully MF |
| |
|
Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
|
| Jones CI, Ford I, Pearse RJ, Chudasama V, Mitchell LR, Watson HG, Watt SJ, Gradwell DP, Batchelor AJ, Rosendaal FR, Meijers JCM, Greaves M, Goodall AH, Toff WD |
| |
|
Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography
|
| Jones CI, Pearse RJ, Chudasama V, Gradwell DP, Batchelor AJ, Goodall AH, Toff WD |
| |
|
Hypothetic Genetic Risk Factors for Preeclampsia or HELLP Syndrome: Probabilities of Risk Factors Present in Fetuses Derived from the Genotypes of the Parents
|
| Moessmer G, Müller B, Artmann A |
| |
|
HZF as a Candidate Gene for Gray Platelet Syndrome (GPS)
|
| Bénit L, Massé JM, Dusanter-Fourt I, Favier R, Cramer EM |
| |
